Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colet

Showing results (571-580 of 608) with videos related to

Pageof 61
Sort By:
Plos One|July 3, 2014
Explicit and implicit emotional expression in bulimia nervosa in the acute state and after recoverySalomé Tárrega, Ana B Fagundo, Susana Jiménez-Murcia, et al.
Journal of the American College of Cardiology|December 16, 2022
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection FractionMikhail N Kosiborod, Ankeet S Bhatt, Brian L Claggett, et al.
Revista Espanola De Cardiologia (English Ed.)|March 24, 2023
Population-based evaluation of the impact of socioeconomic status on clinical outcomes in patients with heart failure in integrated care settingsCristina Capdevila Aguilera, Emili Vela Vallespín, Montse Clèries Escayola, et al.
Journal of the American Heart Association|February 19, 2020
Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON TrialJulio Núñez, Gema Miñana, Ingrid Cardells, et al.
Journal of Internal Medicine|July 12, 2026
Age-stratified effectiveness of a nurse-led heart failure programme: A population-based studyBlanca Torres-Cardús, Emili Vela-Vallespín, David Monterde, et al.
Journal of the American College of Cardiology|August 30, 2022
Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection FractionJawad H Butt, Toru Kondo, Pardeep S Jhund, et al.
Toxicology and Applied Pharmacology|March 29, 2003
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET projectJohn C Lindon, Jeremy K Nicholson, Elaine Holmes, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|January 19, 2019
Planning to reduce 30-day adverse events after discharge of frail elderly patients with acute heart failure: design and rationale for the DEED FRAIL-AHF trialFrancisco Javier Martín-Sánchez, Guillermo Llopis García, Pere Llorens, et al.
International Journal of Integrated Care|March 24, 2025
What Can We Learn for Future Integrated Care Models in Long Term Care Facilities After the COVID-19 Emergency? Lessons From an Observational Study in CataloniaMireia Massot Mesquida, Miquel À Mas, Rosa García-Sierra, et al.
Nature Medicine|March 18, 2023
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trialOrly Vardeny, James C Fang, Akshay S Desai, et al.
Pageof 61

Showing results (571-580 of 608) with videos related to

Sort By:
Pageof 61
Plos One|July 3, 2014
Explicit and implicit emotional expression in bulimia nervosa in the acute state and after recoverySalomé Tárrega, Ana B Fagundo, Susana Jiménez-Murcia, et al.
Journal of the American College of Cardiology|December 16, 2022
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection FractionMikhail N Kosiborod, Ankeet S Bhatt, Brian L Claggett, et al.
Revista Espanola De Cardiologia (English Ed.)|March 24, 2023
Population-based evaluation of the impact of socioeconomic status on clinical outcomes in patients with heart failure in integrated care settingsCristina Capdevila Aguilera, Emili Vela Vallespín, Montse Clèries Escayola, et al.
Journal of the American Heart Association|February 19, 2020
Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON TrialJulio Núñez, Gema Miñana, Ingrid Cardells, et al.
Journal of Internal Medicine|July 12, 2026
Age-stratified effectiveness of a nurse-led heart failure programme: A population-based studyBlanca Torres-Cardús, Emili Vela-Vallespín, David Monterde, et al.
Journal of the American College of Cardiology|August 30, 2022
Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection FractionJawad H Butt, Toru Kondo, Pardeep S Jhund, et al.
Toxicology and Applied Pharmacology|March 29, 2003
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET projectJohn C Lindon, Jeremy K Nicholson, Elaine Holmes, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|January 19, 2019
Planning to reduce 30-day adverse events after discharge of frail elderly patients with acute heart failure: design and rationale for the DEED FRAIL-AHF trialFrancisco Javier Martín-Sánchez, Guillermo Llopis García, Pere Llorens, et al.
International Journal of Integrated Care|March 24, 2025
What Can We Learn for Future Integrated Care Models in Long Term Care Facilities After the COVID-19 Emergency? Lessons From an Observational Study in CataloniaMireia Massot Mesquida, Miquel À Mas, Rosa García-Sierra, et al.
Nature Medicine|March 18, 2023
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trialOrly Vardeny, James C Fang, Akshay S Desai, et al.
Pageof 61